Fresenius Medical Care | FME - Des Atouts

Prix De L'Action
39.76
Variation Quotidienne
0.28 0.71%
Mensuellement
-1.46%
Annuel
-10.25%
Q1 Prévisions
38.35




Des Atouts Changement Date
Akzo Nobel EUR 13.95B 55M 2025-12
Alcon AG USD 31.56B 31M 2025-12
AstraZeneca USD 114.07B 382M 2025-12
Bayer EUR 104.54B 331M 2025-12
Beiersdorf EUR 12.76B 166M 2025-12
DaVita Healthcare Partners USD 17.48B 75.79M 2025-12
Demant DKK 39.07B 6.43B 2025-12
E.ON EUR 110.68B 3.65B 2025-12
Essilor EUR 63.9B 1.97B 2025-12
Fresenius EUR 42.46B 1.14B 2025-09
Fresenius Medical Care EUR 31B 115.33M 2025-12
Genmab DKK 6.46B 122M 2025-06
Getinge SEK 63.92B 4.3B 2024-12
Givaudan CHF 12.18B 1.05B 2024-06
GlaxoSmithKline GBP 61.12B 221M 2025-12
GN Store Nord DKK 29.23B 170M 2025-12
GRIFOLS EUR 19.71B 141.77M 2025-12
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Lonza CHF 19.73B 1.85B 2024-12
Merck EUR 51.53B 600M 2025-12
Novartis USD 107.29B 2.89B 2025-09
Philips EUR 26.94B 605M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
RWE EUR 96.2B 1.6B 2025-09
Sanofi EUR 126.81B 2.99B 2025-12
SAP EUR 70.36B 1.97B 2025-12
Smith & Nephew USD 10.69B 150M 2025-12